Stem Cell Mini Brains Reveal Drug Candidate for Rare Disease
Using three-dimensional “mini-brains” grown from patient-derived induced pluripotent stem cells (iPSCs), researchers at the University of California, San Diego School of Medicine report identifying a drug candidate that can reverse cellular dysfunction in MECP2 duplication syndrome by suppressing a key genetic abnormality. The study appears in the September 8 online issue of Molecular Psychiatry. MECP2 … Read more